FDA approves first wearable device to monitor glucose and ketone levels simultaneously in diabetes patients

The US Food and Drug Administration has authorised the Libre Duo 10 Day system, a groundbreaking wearable that tracks glucose and ketone levels simultaneously, potentially transforming diabetic ketoacidosis prevention and management. The US Food and Drug Administration has authorised the…













